CIBC ASSET MANAGEMENT INC – Regeneron Pharmaceuticals, Inc. Transaction History
CIBC ASSET MANAGEMENT INC portfolio value:
$18.38M
portfolio value
CIBC ASSET MANAGEMENT INC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +6.42% | 1.61K shares | 3.56M | $688.87 | 26.68K |
| Q2 2022 | share | Decrease | -1.01% | -256 shares | -2.86M | $591.13 | 25.07K |
| Q1 2022 | share | Decrease | -2.86% | -747 shares | 1.22M | $698.42 | 25.33K |
| Q4 2021 | share | Increase | +8.51% | 2.04K shares | 1.92M | $642.51 | 26.07K |
| Q3 2021 | share | Increase | +0.65% | 156 shares | 1.20M | $605.18 | 24.03K |
| Q2 2021 | share | Increase | +5.72% | 1.29K shares | 2.65M | $558.54 | 23.87K |
| Q1 2021 | share | Increase | +15.61% | 3.04K shares | 1.24M | $473.14 | 22.58K |
| Q4 2020 | share | Increase | +6.99% | 1.27K shares | -783K | $483.11 | 19.53K |
| Q3 2020 | share | Increase | +18.82% | 2.89K shares | 638K | $559.78 | 18.25K |
| Q2 2020 | share | Increase | +7.36% | 1.05K shares | 2.59M | $623.65 | 15.36K |
| Q1 2020 | share | Increase | +0.17% | 24 shares | 1.62M | $488.29 | 14.31K |
| Q4 2019 | share | Increase | +5.44% | 737 shares | 1.60M | $375.48 | 14.28K |
| Q3 2019 | share | Decrease | -1.20% | -164 shares | -533K | $277.4 | 13.55K |
| Q2 2019 | share | Increase | +2.77% | 369 shares | -1.18M | $313 | 13.71K |
| Q1 2019 | share | Decrease | -0.62% | -83 shares | 465K | $410.62 | 13.34K |
| Q4 2018 | share | Increase | +2.07% | 272 shares | -301K | $373.5 | 13.42K |
| Q3 2018 | share | Increase | +2.06% | 266 shares | 869K | $404.04 | 13.15K |
| Q2 2018 | share | Increase | +4.92% | 605 shares | 217K | $344.99 | 12.89K |
| Q1 2018 | share | Decrease | -0.27% | -33 shares | -401K | $344.36 | 12.28K |
| Q4 2017 | share | Increase | +5.43% | 634 shares | -593K | $375.96 | 12.31K |
| Q3 2017 | share | Increase | +2.31% | 264 shares | -385K | $447.12 | 11.68K |
| Q2 2017 | share | Increase | +3.84% | 422 shares | 1.34M | $491.14 | 11.42K |
| Q1 2017 | share | Increase | +2.74% | 293 shares | 332K | $387.51 | 10.99K |
| Q4 2016 | share | Decrease | -0.72% | -78 shares | -405K | $367.09 | 10.70K |
| Q3 2016 | share | Decrease | -5.31% | -605 shares | 358K | $402.02 | 10.78K |
| Q2 2016 | share | Increase | +1.56% | 175 shares | -65K | $349.23 | 11.38K |
| Q1 2016 | share | Increase | +2.77% | 302 shares | -1.88M | $360.44 | 11.21K |